Right To Live 2016

Hemophilia associations across Asia expressed alarm over the recent decision of the Indian government to impose taxes and duties for 76 life-saving drugs including anti-hemophilic factors, considered the life-line for persons with hemophilia (PWHs) and bleeding disorders. “Lives of patients should not be compromised in any situation. In the ‘80s and ‘90s, we have witnessed how thousands of PWHs and bleeding disorders across America and Europe died because of tainted anti-hemophilic products,” “We support the move of the government to strengthen Make In India campaign. However, this should not be imposed on products, such as anti-hemophilic factors, that have not passed global quality standards..." Mukesh Garodia, executive committee member of the Hemophilia Federation India, said It's India today. Who knows where else tomorrow.